Patients with estrogen-receptor-positive HER-2-negative advanced breast cancer showed significantly improved progression-free ...

In a landmark moment at the ESMO Congress 2025, pivotal studies have unveiled compelling evidence that a new class of ...

RFK Jr.’s moves to limit animal testing in drug trials could pull animal rights voters into the Republican camp, experts say.

Fatal overdoses in the US are falling - and Kayla's state of North Carolina is at the forefront of that trend.

AstraZeneca and Daiichi Sankyo’s star drug Enhertu has delivered a double knockout, showing its ability to stave off early ...

Drugmaker EMD Serono will reduce the cost of a common fertility medication through a deal struck with the Trump ...

Neoadjuvant Enhertu then THP improved pathological complete response rate in patients with high-risk, HER2-positive early ...

Enhertu significantly improved IDFS compared to Kadcyla, with a 53% risk reduction in invasive disease or death in high-risk, ...

Dr. Erica MayerPatients with estrogen-receptor-positive HER-2-negative advanced breast cancer showed significantly improved progression-free survival ...

T-DXd significantly improved IDFS and reduced the risk of invasive disease or death by 53% compared to T-DM1 in high-risk, HER2-positive breast cancer patients. The trial demonstrated superior ...

Enfortumab vedotin and pembrolizumab with surgery significantly improve outcomes in cisplatin-ineligible MIBC patients, ...

In a landmark moment at the ESMO Congress 2025, pivotal studies have unveiled compelling evidence that a new class of anti-cancer ...